Get the Stockscreener App
0.00
100.00%
-70.98
Axonics Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.
See More
Previous Close:
$70.98
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$3.63B
Revenue:
$431.90M
Net Income/Loss:
$-5.66M
P/E Ratio:
0.00
EPS:
-0.25
Net Cash Flow:
$5.37M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$71.05
Axonics Inc Stock (AXNX) Company Profile
Name
Axonics Inc
Sector
Industry
Phone
949-396-6322
Address
26 TECHNOLOGY DRIVE, IRVINE, CA
Compare AXNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AXNX
Axonics Inc
|
0.00 | 3.63B | 431.90M | -5.66M | 5.37M | -0.1204 |
|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
Axonics Inc Stock (AXNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jul-13-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-23-23 | Initiated | CL King | Buy |
| Apr-14-23 | Initiated | Mizuho | Buy |
| Mar-24-23 | Upgrade | Needham | Hold → Buy |
| Oct-21-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Oct-10-22 | Downgrade | Needham | Buy → Hold |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jul-12-21 | Initiated | Barclays | Overweight |
| Jun-28-21 | Reiterated | Needham | Buy |
| Nov-05-20 | Reiterated | Needham | Buy |
| Oct-23-20 | Initiated | Guggenheim | Buy |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-07-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Nov-01-19 | Initiated | Piper Jaffray | Overweight |
| Oct-21-19 | Initiated | Barclays | Overweight |
| Sep-17-19 | Initiated | SVB Leerink | Outperform |
| Sep-09-19 | Reiterated | Needham | Buy |
| Sep-03-19 | Initiated | Needham | Buy |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| Nov-26-18 | Initiated | BofA/Merrill | Buy |
| Nov-26-18 | Initiated | Morgan Stanley | Overweight |
| Nov-26-18 | Initiated | SunTrust | Buy |
| Nov-26-18 | Initiated | Wells Fargo | Outperform |
View All
Axonics Inc Stock (AXNX) Latest News
Boston Scientific stock holds rating after Axonics acquisition - Investing.com
UroMems Appoints Former Axonics Executive Rinda Sama to Board of Directors - PR Newswire UK
Boston Sci. Completes $3.7B Axonics Buy - Orange County Business Journal
Thibodaux Regional Urology Clinic Recognized as an Axonics® Center of Excellence - Lafourche Gazette
Boston Scientific Stock Set to Gain From Completion of Axonics Deal - MSN
Axonics, Inc. (NASDAQ:AXNX) Stock Holdings Raised by Alpine Associates Management Inc. - MarketBeat
Axonics Modulation Technologies (AXNX) Q3 Earnings and Revenues Top Estimates - MSN
Boston Scientific Completes $3.7B Acquisition of Axonics - Orange County Business Journal
Boston Scientific Completes Strategic Acquisition of Axonics - Zenopa
LMR Partners LLP Reduces Stock Holdings in Axonics, Inc. (NASDAQ:AXNX) - MarketBeat
Boston Scientific Completes Acquisition of Axonics - Zenopa
Boston Scientific acquires Axonics - Medical Buyer
Boston Scientific Closes Acquisition of Axonics - FinSMEs
SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors - The Manila Times
Short Interest in Axonics, Inc. (NASDAQ:AXNX) Grows By 5.4% - MarketBeat
Boston Scientific (BSX) Completes Acquisition of Axonics - GuruFocus.com
Boston Scientific completes $3.7B purchase of California bowel dysfunction company - Worcester Business Journal
Boston Scientific finalizes $3.7B acquisition of Axonics - Mass Device
Boston Scientific closes $3.7B Axonics deal after lengthy review - MedTech Dive
Boston Sci Closes Acquisition of Medtronic’s Neuromodulation Foe - MD+DI
Boston Scientific Closes $3.7B Deal for Axonics - MPO-mag
Boston Scientific closes acquisition of Axonics, Inc - Med-Tech Innovation
Axonics Modulation Technologies Merges and Delists from Nasdaq - TipRanks
Axonics, Inc. Announces Management Changes - Marketscreener.com
Boston Scientific Completes $3.7B Axonics Acquisition, Expands Urology Portfolio | BSX Stock News - StockTitan
Axonics, Inc. (NASDAQ:AXNX) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Axonics stock soars to 52-week high, reaches $70.93 By Investing.com - Investing.com Australia
Axonics stock soars to 52-week high, reaches $70.93 - Investing.com India
Axonics gains after Nasdaq delisting notice for sale to Boston Scientific - MSN
SoniVie Names Axonics' Raymond Cohen as Chairman Following $3.7B Boston Scientific Deal | BSX Stock News - StockTitan
Versor Investments LP Sells 30,587 Shares of Axonics, Inc. (NASDAQ:AXNX) - MarketBeat
Axonics’ Q3 2024: Revenue Growth Amid Challenges - TipRanks
Axonics' (AXNX) "Hold" Rating Reiterated at Needham & Company LLC - MarketBeat
Axonics: Q3 Earnings Snapshot - Houston Chronicle
Axonics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Axonics Reports Third Quarter 2024 Financial Results - BioSpace
Axonics Inc (AXNX) Q3 2024 Earnings: Revenue Hits $116.2 Million, Surpassing Estimates - GuruFocus.com
Medtronic Says Axonics Misled Jury To Beat Patent Case - Law360
Axonics stock soars to 52-week high, reaches $70.6 - Investing.com
Axonics stock soars to 52-week high, reaches $70.6 By Investing.com - Investing.com UK
Axonics’ Market Growth Strengthens Boston Scientific’s Future (NASDAQ:AXNX) - Seeking Alpha
Boston Scientific Announces Agreement to Acquire Cortex, Inc. - StockTitan
Axonics, Inc. (NASDAQ:AXNX) Shares Sold by Oak Ridge Investments LLC - MarketBeat
Axonics Inc Stock (AXNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):